The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The US Food and Drug Administration (FDA) announced today that it will only recommend COVID-19 vaccines for adults 65 and ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...